These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
451 related items for PubMed ID: 17367211
21. Rare Functional Variants in Complement Genes and Anti-FH Autoantibodies-Associated aHUS. Valoti E, Alberti M, Iatropoulos P, Piras R, Mele C, Breno M, Cremaschi A, Bresin E, Donadelli R, Alizzi S, Amoroso A, Benigni A, Remuzzi G, Noris M. Front Immunol; 2019; 10():853. PubMed ID: 31118930 [Abstract] [Full Text] [Related]
22. Factor H Competitor Generated by Gene Conversion Events Associates with Atypical Hemolytic Uremic Syndrome. Goicoechea de Jorge E, Tortajada A, García SP, Gastoldi S, Merinero HM, García-Fernández J, Arjona E, Cao M, Remuzzi G, Noris M, Rodríguez de Córdoba S. J Am Soc Nephrol; 2018 Jan; 29(1):240-249. PubMed ID: 28993505 [Abstract] [Full Text] [Related]
23. Clinical and Genetic Characteristics of Atypical Hemolytic Uremic Syndrome in Children: A Chinese Cohort Study. Wu D, Chen J, Ling C, Chen Z, Fan J, Sun Q, Meng Q, Liu X. Nephron; 2021 Jan; 145(4):415-427. PubMed ID: 33873197 [Abstract] [Full Text] [Related]
27. High prevalence of CFHR deletions in Indian women with pregnancy-associated hemolytic uremic syndrome. Kandari S, Chakurkar V, Gaikwad S, Agarwal M, Phadke N, Lobo V. Nephrology (Carlton); 2022 Mar; 27(3):231-237. PubMed ID: 34796567 [Abstract] [Full Text] [Related]
28. Anti-factor H antibody and its role in atypical hemolytic uremic syndrome. Raina R, Mangat G, Hong G, Shah R, Nair N, Abboud B, Bagga S, Sethi SK. Front Immunol; 2022 Mar; 13():931210. PubMed ID: 36091034 [Abstract] [Full Text] [Related]
29. Variants in Complement Factor H and Complement Factor H-Related Protein Genes, CFHR3 and CFHR1, Affect Complement Activation in IgA Nephropathy. Zhu L, Zhai YL, Wang FM, Hou P, Lv JC, Xu DM, Shi SF, Liu LJ, Yu F, Zhao MH, Novak J, Gharavi AG, Zhang H. J Am Soc Nephrol; 2015 May; 26(5):1195-204. PubMed ID: 25205734 [Abstract] [Full Text] [Related]
30. Complement factor H related proteins in immune diseases. Skerka C, Zipfel PF. Vaccine; 2008 Dec 30; 26 Suppl 8():I9-14. PubMed ID: 19388158 [Abstract] [Full Text] [Related]
32. Atypical haemolytic-uraemic syndrome due to heterozygous mutations of CFH/CFHR1-3 and complement factor H 479. Chaudhary P, Hepgur M, Sarkissian S, Smith RJ, Weitz IC. Blood Transfus; 2014 Jan 30; 12(1):111-3. PubMed ID: 24333077 [No Abstract] [Full Text] [Related]
33. Carfilzomib-induced aHUS responds to early eculizumab and may be associated with heterozygous CFHR3-CFHR1 deletion. Portuguese AJ, Lipe B. Blood Adv; 2018 Dec 11; 2(23):3443-3446. PubMed ID: 30518536 [Abstract] [Full Text] [Related]
36. Complement Genetic Variants and FH Desialylation in S. pneumoniae-Haemolytic Uraemic Syndrome. Gómez Delgado I, Corvillo F, Nozal P, Arjona E, Madrid Á, Melgosa M, Bravo J, Szilágyi Á, Csuka D, Veszeli N, Prohászka Z, Sánchez-Corral P. Front Immunol; 2021 Dec 11; 12():641656. PubMed ID: 33777036 [Abstract] [Full Text] [Related]
37. Associations of CFHR1-CFHR3 deletion and a CFH SNP to age-related macular degeneration are not independent. Raychaudhuri S, Ripke S, Li M, Neale BM, Fagerness J, Reynolds R, Sobrin L, Swaroop A, Abecasis G, Seddon JM, Daly MJ. Nat Genet; 2010 Jul 11; 42(7):553-5; author reply 555-6. PubMed ID: 20581873 [No Abstract] [Full Text] [Related]
38. Anti-factor H autoantibodies in C3 glomerulopathies and in atypical hemolytic uremic syndrome: one target, two diseases. Blanc C, Togarsimalemath SK, Chauvet S, Le Quintrec M, Moulin B, Buchler M, Jokiranta TS, Roumenina LT, Fremeaux-Bacchi V, Dragon-Durey MA. J Immunol; 2015 Jun 01; 194(11):5129-38. PubMed ID: 25917093 [Abstract] [Full Text] [Related]